9858 Federal Register / Vol. 89, No. 29 / Monday, February 12, 2024 / Notices 

As part of that review, the online survey 

will be used to: 

Measure the effect of the 2016–2017 

HIPAA Audits on covered entities’ and 

business associates’ subsequent actions 

to comply with the HIPAA Rules. 

Provide entities with an opportunity 

to give feedback on the Audit and its 

features, such as the helpfulness of 

HHS’ guidance materials and 

communications, the utility of the 

online submission portal, whether the 

Audit helped improve entity 

compliance, and the entities’ responses 

to the Audit-report findings and 

recommendations. 

Provide OCR with information on the 

burden imposed on entities to collect 

audit-related documents and to respond 

to audit-related requests; and 

Seek feedback on the effect of the 

HIPAA Audit program on the entities’ 

day-to-day business operations. 

The information, opinions, and 

comments collected using the online 

survey will be used to improve future 

OCR HIPAA Audits. 

ANNUALIZED BURDEN HOUR TABLE

Form name Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

Total 

burden 

hours 

OCR HIPAA Audit Participant Survey.Covered Entity Privacy and Security 

Officer(s) or Administrators.

166 1 45/60 124.5 

OCR HIPAA Audit Participant Survey.Business Associate Privacy and Security Officer(s) or Administrators.41 1 45/60 30.75 

Total ........................................... ........................................................... 207 ........................ ........................ 155.25 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2024–02737 Filed 2–9–24; 8:45 am] 

BILLING CODE 4153–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Maximizing 

Investigators’ Research Award—E Study 

Section, March 05, 2024, 8 a.m. to 

March 6, 2024, 6 p.m., Center for 

Scientific Review, RKL2, 6701 

Rockledge Dr, Bethesda, MD, 20817 

which was published in the Federal 

Register on February 06, 2024, 89 FR 

8218, Doc 2024–02265. 

This meeting is being amended to 

change the meeting start time from 8 

a.m. to 9 a.m. The meeting is closed to 

the public. 

Dated: February 6, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–02775 Filed 2–9–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Investigator Initiated 

Extended Clinical Trial (R01 Clinical Trial 

Required). 

Date: March 8, 2024. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Rockville, MD 

20892 (Video Assisted Meeting). 

Contact Person: Lindsey M. Pujanandez, 

Ph.D., Scientific Review Officer, Immunology 

Review Branch, Scientific Review Program, 

Division of Extramural Activities, National 

Institute of Allergy and Infectious Diseases, 

National Institutes of Health, 5601 Fishers 

Lane, MSC 9834, Rockville, MD 20852, (240) 

627–3206, lindsey.pujanandez@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: February 6, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–02773 Filed 2–9–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; URGenT: Translational 

Efforts to Advance Gene-based Therapies for 

Ultra-Rare Neurological and Neuromuscular 

Disorders. 

Date: February 27, 2024. 

Time: 10:00 a.m. to 1:00 p.m. 


khammond on DSKJM1Z7X2PROD with NOTICES